• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. TRUE FLOW DILATATION CATHETER; BALLOON VALVULOPLASTY CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. TRUE FLOW DILATATION CATHETER; BALLOON VALVULOPLASTY CATHETER Back to Search Results
Catalog Number TF0243514
Device Problems Peeled/Delaminated (1454); Retraction Problem (1536); Material Rupture (1546)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 06/23/2016
Event Type  malfunction  
Manufacturer Narrative
No hospital/medical records or medical images have been made available to the manufacturer.As the lot number for the device was provided, a review of the device history records is currently being performed.The device has been returned to the manufacturer for evaluation.The investigation of the reported event is currently underway.The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Event Description
It was reported that during an aortic valvuloplasty, one of the eight balloons allegedly ruptured after four seconds of inflation using a 30cc syringe.There was no reported retraction issues.The balloon was replaced with a new aortic valve to complete the procedure.There was no reported patient injury.
 
Manufacturer Narrative
Manufacturing review: a manufacturing review was conducted and there was nothing found to indicate there was a manufacturing related cause for this event.The lot met all release criteria.Visual/microscopic inspection: the balloon size for this product is printed on the balloon hub of the catheter and identified the returned sample as a 24mm x 3.5cm balloon.The outer balloon jacket was received completely detached from the balloon.However, per the reported event details the technician completely removed the jacket from the balloon after the procedure was completed.A small amount of fluid was still present inside the balloons, indicating that the balloons were not completely deflated.No other anomalies were noted to the device at this time.Functional/performance evaluation: the patency of the guidewire lumen was then tested using an in-house 0.035¿ guidewire, and it passed with no issues.The inflation hub was then connected to a max30 inflation device and an attempt was made to inflate the balloon with water.Upon inflation, water was observed leaking from one of the balloons.The balloon was placed under microscopic magnification (10x) and a longitudinal rupture was observed on the barrel of the balloon, measuring 4.6cm in length.Medical records review: medical records were not provided; therefore, a review could not be performed.Image/photo review: three electronic photos were reviewed by derrick loud (field assurance engineer).The first two photo show the balloon profile of a true flow valvuloplasty perfusion catheter placed on a gauze pad.The outer balloon jacket is partially peeling off of the balloon and prolapsed over the distal portion of the jacket.The balloon does not appear to be completely deflated.One of the balloons appears to be more deflated that the rest of the balloons.The third photo shows the outer balloon jacket completely removed from the true flow balloon.Based on the photos provided, the investigation is confirmed for peeling of the outer balloon jacket and sheath retraction problems.Conclusion: the investigation is confirmed for a longitudinal rupture on the barrel of the balloon, deflation issues, sheath retraction problems, and peeling of the outer jacket.The balloon rupture likely resulted in the inability to completely deflate the balloon, which lead to the sheath retraction problems and the peeling of the outer jacket.The current ifu (instructions for use) states "do not exceed the rbp recommended for this device.Balloon rupture may occur if the rbp rating is exceeded.To prevent over pressurization, use of a pressure monitoring device is recommended." additionally, the ifu states to use a luer lock syringe/inflation device with manometer (50ml or larger).As a 30cc syringe was used with no pressure monitoring device it is possible that the balloon was over-pressurized, causing the balloon to rupture.However, the definitive root cause for the balloon rupture could not be determined based upon the available information.It is unknown if patient and/or procedural issues contributed to the reported event.Labeling review: the current true flow balloon dilatation catheter instructions for use (ifu) provides general instructions for use of the device, as well as warnings, precautions, and potential complications associated with the device.Additional information: expiry date: date received by manufacturer; type of report - mdr; type of follow up; manufacturing date; (b)(4).Update: device evaluated; evaluation summary attached; device not evaluated code; (b)(4).The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Event Description
It was reported that during an aortic valvuloplasty, one of the eight balloons allegedly ruptured after four seconds of inflation using a 30cc syringe.There was no reported retraction issues.The balloon was replaced with a new aortic valve to complete the procedure.There was no reported patient injury.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRUE FLOW DILATATION CATHETER
Type of Device
BALLOON VALVULOPLASTY CATHETER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury NY 12804
Manufacturer Contact
judith ludwig
1625 w 3rd st.
tempe, AZ 85281
4803032689
MDR Report Key5798414
MDR Text Key49665110
Report Number2020394-2016-00646
Device Sequence Number1
Product Code OZT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K142083
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,user f
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 06/23/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/28/2017
Device Catalogue NumberTF0243514
Device Lot NumberGFAS2180
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/01/2016
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 06/23/2016
Initial Date FDA Received07/15/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received09/22/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/08/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age81 YR
-
-